These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9054324)

  • 61. [Etiologic characteristics of Vibrio cholerae in Guangdong province in 2009-2013].
    Li B; Tan H; Wang D; Ke B; Chen J; He D; Liu M; Ke C; Zhang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jul; 35(7):825-31. PubMed ID: 25294076
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Features of Vibrio cholerae 0:1 El Tor, Inaba serotype, isolated during the cholera epidemic in Cartagena (Colombia)].
    Salim Máttar V
    Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):525-30. PubMed ID: 1489792
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assessing clonality of Vibrio cholerae strains isolated during four consecutive years (2004 - 2007) in Iran.
    Bakhshi B; Pourshafie MR
    Scand J Infect Dis; 2009; 41(4):256-62. PubMed ID: 19253091
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Phenotypic and genotypic characterization of Vibrio cholerae O1].
    Giono-Cerezo S; Rodríguez Angeles MG; Gutiérrez-Cogco L; Valdespino-Gómez JL
    Rev Latinoam Microbiol; 1994; 36(4):243-51. PubMed ID: 7701133
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Characterization of a multiresistant strain of Vibrio cholerae O1, isolated from a case of cholera in Chile].
    Castillo L; Ulloa MT; Martínez MA; Silva W; Seoane M; Maldonado A; Castillo P
    Rev Med Chil; 1994 Sep; 122(9):986-92. PubMed ID: 7597345
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of Vibrio cholerae from 1986 to 2012 in Yunnan Province, southwest China bordering Myanmar.
    Gu W; Yin J; Yang J; Li C; Chen Y; Yin J; Xu W; Zhao S; Liang J; Jing H; Fu X
    Infect Genet Evol; 2014 Jan; 21():1-7. PubMed ID: 24177595
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Changing pattern of Vibrio cholerae serotype EL TOR and 0139 in Yavatmal (Maharashtra, India) during 1992 to 1994.
    Ingole KV; Jalgaonkar SV; Fule C; Fule RP
    Indian J Pathol Microbiol; 1997 Jul; 40(3):369-71. PubMed ID: 9354010
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cholera epidemic in Goa.
    Verenkar M; Savio R; Venkatesh N; Pinto MJ; Singh I
    Indian J Pathol Microbiol; 1994 Jul; 37(3):289-92. PubMed ID: 7814060
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India.
    Krishna BV; Patil AB; Chandrasekhar MR
    Trans R Soc Trop Med Hyg; 2006 Mar; 100(3):224-6. PubMed ID: 16246383
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Molecular epidemiology of Vibrio cholerae O-1 from outbreak and sporadic patients in Nagoya in 1989].
    Mori M; Agata N; Murase Y; Ohta M
    Kansenshogaku Zasshi; 1991 Jul; 65(7):833-7. PubMed ID: 1919114
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Experimental resistance of Vibrio cholerae el tor to nalidixic acid and fluoroquinolones].
    Ryzhko IV; Tsuraeva RI; Lomov IuM; Shut'ko AG; Mishan'kin BN; Koroleva NS; Samokhodkina ED; Shcherbaniuk AI
    Antibiot Khimioter; 2000; 45(9):7-12. PubMed ID: 11057367
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antibiotic resistance conferred by a conjugative plasmid and a class I integron in Vibrio cholerae O1 El Tor strains isolated in Albania and Italy.
    Falbo V; Carattoli A; Tosini F; Pezzella C; Dionisi AM; Luzzi I
    Antimicrob Agents Chemother; 1999 Mar; 43(3):693-6. PubMed ID: 10049292
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Routine use of antimicrobial drugs during the 2004 cholera epidemic in Douala, Cameroon.
    Noeske J; Guévart E; Kuaban C; Solle J; Fonkoua MC; Mouangue A; Fouda AB
    East Afr Med J; 2006 Nov; 83(11):596-601. PubMed ID: 17455448
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characteristics of a cholera outbreak, patterns of Vibrio cholerae and antibiotic susceptibility testing in rural Malawi.
    Zachariah R; Harries AD; Arendt V; Nchingula D; Chimtulo F; Courteille O; Kirpach P
    Trans R Soc Trop Med Hyg; 2002; 96(1):39-40. PubMed ID: 11925988
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh.
    Glass RI; Huq I; Alim AR; Yunus M
    J Infect Dis; 1980 Dec; 142(6):939-42. PubMed ID: 7462703
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Multidrug-resistant IncA/C plasmid in Vibrio cholerae from Haiti.
    Folster JP; Katz L; McCullough A; Parsons MB; Knipe K; Sammons SA; Boncy J; Tarr CL; Whichard JM
    Emerg Infect Dis; 2014 Nov; 20(11):1951-3. PubMed ID: 25340576
    [No Abstract]   [Full Text] [Related]  

  • 77. Molecular Adaptations and Antibiotic Resistance in
    Narendrakumar L; Gupta SS; Johnson JB; Ramamurthy T; Thomas S
    Microb Drug Resist; 2019 Sep; 25(7):1012-1022. PubMed ID: 31021308
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Vellore Vibrio watch 1996-98.
    Jesudason MV; Mukundan U; John TJ
    Trans R Soc Trop Med Hyg; 1999; 93(6):595-6. PubMed ID: 10717740
    [No Abstract]   [Full Text] [Related]  

  • 79. [Characterization of Vibrio cholerae cultures isolated in foci of cholera in the city of Kazan].
    Ziatdinov VB
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (6):78-80. PubMed ID: 12506636
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Distribution and content of class 1 integrons in different Vibrio cholerae O-serotype strains isolated in Thailand.
    Dalsgaard A; Forslund A; Serichantalergs O; Sandvang D
    Antimicrob Agents Chemother; 2000 May; 44(5):1315-21. PubMed ID: 10770768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.